Osman O Atiq

Researcher

UAMS primary Harding University

Also affiliated: Duke University (2021); St. Matthew's University (2018–2021); Unity Health System (2020–2021); Duke Medical Center (2021); Winthrop Rockefeller Foundation (2018)

Unknown Researcher

3 h-index 5 pubs 26 cited

Research Areas

Biomedical Subjects

OverviewAI-generated summary

Osman O Atiq is a researcher at the University of Arkansas for Medical Sciences. His work has focused on the study of medical case reports, particularly in the context of cancer treatment and the immune response. He has co-authored publications examining metastatic pancreatic adenocarcinoma treated with chemotherapy and immunotherapy, and another on proton beam accelerated partial breast irradiation in a phase II trial. Atiq's scholarship metrics include an h-index of 3, with 5 total publications and 26 total citations. He has collaborated with Zainab Atiq on one shared publication.

Metrics

h-index: 3
Publications: 5
Citations: 26

Selected Publications

A Case of Metastatic Pancreatic Adenocarcinoma in Complete Remission Using Chemotherapy and Immunotherapy (2021)

Cureus 7 citations DOI OpenAlex
Pembrolizumab-Induced Cold Agglutinin Disease (2020)

American Journal of Case Reports 9 citations DOI OpenAlex
USING AN AGE-EQUALIZED HEART SCORE TO PREDICT INPATIENT WORKUP OF CHEST PAIN (2020)

Journal of the American College of Cardiology DOI OpenAlex
The Role of Immunotherapy and Radiation Therapy in Tumor Chemosensitivity in Advanced Head and Neck Cancer (2018)

American Journal of Case Reports 8 citations DOI OpenAlex